Evidence map›Paper›PMID 30967617›Full record

ArticleLeukemia2019

STAT5B

Klara Klein, Agnieszka Witalisz-Siepracka, Barbara Maurer, Daniela Prinz, Gerwin Heller, Nicoletta Leidenfrost, Michaela Prchal-Murphy, Tobias Suske, Richard Moriggl, Veronika Sexl

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. STAT5 as a Key Protein of Erythropoietin Signalization.International journal of molecular sciences · 2021
    Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Klara KleinInstitute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, Vienna, Austria.
Agnieszka Witalisz-SieprackaInstitute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, Vienna, Austria.
Barbara MaurerInstitute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, Vienna, Austria.
Daniela PrinzInstitute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, Vienna, Austria.
Gerwin HellerInstitute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0001-8742-5631
Nicoletta LeidenfrostInstitute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, Vienna, Austria.
Michaela Prchal-MurphyInstitute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, Vienna, Austria.
Tobias SuskeInstitute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, Vienna, Austria.
Richard MorigglInstitute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0003-0918-9463
Veronika SexlInstitute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, Vienna, Austria. veronika.sexl@vetmeduni.ac.at.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsCD56 AntigenCD8-Positive T-LymphocytesDisease Models, AnimalHumansLeukemia, Large Granular LymphocyticMiceMice, TransgenicNatural Killer T-CellsSTAT5 Transcription FactorCD56 AntigenNCAM1 protein, humanSTAT5B protein, humanSTAT5 Transcription Factor

Identifiers

PMID30967617
PMCPMC6756040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.